Middle Ear Implants (MEI): Vibrant Soundbridge

Chapter

Abstract

The Vibrant Soundbridge® (VSB) is a middle ear hearing implant what was first implanted in 1996 as a treatment for moderate to severe sensorineural hearing loss. In February 1998, the device was approved with the CE mark and in August 2000 by the Food and Drug Administration (FDA) as well. Thousands of patients around the world have been implanted with the VSB since 1996. Remarkable patient satisfaction and performance of the device have been reported in scientific publications and presentations. In general, patients who wear the device all day long (up to about 16 h) report a natural sound quality, high device satisfaction, and a better ability to understand speech, especially in noisy environment [1]. Since 2007 the VSB is also approved as a treatment for conductive and mixed hearing loss and in 2009 the VSB got the approval for implantation in children by the EU authorities. The VSB has also proved to be a very reliable device, with a cumulative survival rate of 98.3 % after a period of 105 months.

Keywords

External Auditory Canal Round Window Chronic Otitis Medium Oval Window Round Window Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Luetje CM, Brackman D, Balkany TJ, Maw J, Baker RS, Kelsall D, Backous D, Miyamoto R, Parisier S, Arts A. Phase III clinical trial results with the Vibrant Soundbridge implantable middle ear hearing device: a prospective controlled multicenter study. Otolaryngol Head Neck Surg. 2002;126(2):97–107.PubMedCrossRefGoogle Scholar
  2. 2.
    Fisch U, Cremers CW, Lenarz T, Weber B, Babighian G, Uziel AS, Proops DW, O’Connor AF, Charachon R, Helms J, Fraysse B. Clinical experience with the Vibrant Soundbridge implant device. Otol Neurotol. 2001;22(6):962–72.PubMedCrossRefGoogle Scholar
  3. 3.
    Colletti L, Mandalà M, Colletti V. Long-term outcome of round window Vibrant Soundbridge implantation in extensive ossicular chain defects. Otolaryngol Head Neck Surg. 2013;149(1):134–41. doi: 10.1177/0194599813486255. Epub 2013 Apr 12.PubMedCrossRefGoogle Scholar
  4. 4.
    Colletti V, Soli SD, Carner M, Colletti L. Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window. Int J Audiol. 2006;45(10):600–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Baumgartner WD, Böheim K, Hagen R, Müller J, Lenarz T, Reiss S, Schlögel M, Mlynski R, Mojallal H, Colletti V, Opie J. The Vibrant Soundbridge for conductive and mixed hearing losses: European multicenter study results. Adv Otorhinolaryngol. 2010;69:38–50.PubMedGoogle Scholar
  6. 6.
    Skarzynski H, Olszewski L, Skarzynski PH, Lorens A, Piotrowska A, Porowski M, Mrowka M, Pilka A. Direct round window stimulation with the Med-El Vibrant Soundbridge: 5 years of experience using a technique without interposed fascia. Eur Arch Otorhinolaryngol. 2014;271(3):477–82. doi: 10.1007/s00405-013-2432-1. Epub 2013 Mar 20.
  7. 7.
    Snik AF, Mylanus EA, Cremers CW, Dillier N, Fisch U, Gnadeberg D, Lenarz T, Mazolli M, Babighian G, Uziel AS, Cooper HR, O’Connor AF, Fraysse B, Charachon R, Shehata-Dieler WE. Multicenter audiometric results with the Vibrant Soundbridge, a semi-implantable hearing device for sensorineural hearing impairment. Otolaryngol Clin North Am. 2001;34(2):373–88.PubMedCrossRefGoogle Scholar
  8. 8.
    Pau HW, Just T. Third window vibroplasty: an alternative in surgical treatment of tympanosclerotic obliteration of the oval and round window niche. Otol Neurotol 2010;31:225–227.PubMedCrossRefGoogle Scholar
  9. 9.
    Frenzel H, Schönweiler R, Hanke F, Steffen A, Wollenberg B. The Lübeck flowchart for functional and aesthetic rehabilitation of aural atresia and microtia. Otol Neurotol. 2012;33(8):1363–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Mandalà M, Colletti L, Colletti V. Treatment of the atretic ear with round window Vibrant Soundbridge implantation in infants and children: electrocochleography and audiologic outcomes. Otol Neurotol. 2011;32(8):1250–5.PubMedCrossRefGoogle Scholar
  11. 11.
    McKinnon BJ, Dumon T, Hagen R, Lesinskas E, Mlynski R, Profant M, Spindel J, Van Beek-King J, Zernotti M. Vibrant Soundbridge in aural atresia: does severity matter? Eur Arch Otorhinolaryngol. 2014;271(7):1917–21. doi: 10.1007/s00405-013-2680-0. Epub 2013 Sep 13.
  12. 12.
    Zernotti ME, Arauz SL, Di Gregorio MF, Arauz SA, Tabernero P, Romero MC. Vibrant Soundbridge in congenital osseous atresia: multicenter study of 12 patients with osseous atresia. Acta Otolaryngol. 2013;133(6):569–73.PubMedCrossRefGoogle Scholar
  13. 13.
    Streitberger C, Perotti M, Beltrame MA, Giarbini N. Vibrant Soundbridge for hearing restoration after chronic ear surgery. Rev Laryngol Otol Rhinol (Bord). 2009;130(2):83–8.Google Scholar
  14. 14.
    Huber AM, Mlynski R, Müller J, Dillier N, Holzmann D, Wolframm MD, Hagen R. New vibroplasty coupling technique as a treatment for conductive and mixed hearing losses: a report of 4 cases. Otol Neurotol. 2012;33(4):613–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Luers JC, Hüttenbrink KB, Zahnert T, Bornitz M, Beutner D. Vibroplasty for mixed and conductive hearing loss. Otol Neurotol. 2013;34(6):1005–12.PubMedCrossRefGoogle Scholar
  16. 16.
    Sprinzl GM, Wolf-Magele A, Schnabl J, Koci V. The active middle ear implant for the rehabilitation of sensorineural, mixed and conductive hearing losses. Laryngorhinootologie. 2011;90(9):560–72.PubMedCrossRefGoogle Scholar
  17. 17.
    Zernotti ME, Gregorio MF, Sarasty AC. Middle ear implants: functional gain in mixed hearing loss. Braz J Otorhinolaryngol. 2012;78(1):109–12.PubMedCrossRefGoogle Scholar

Copyright information

© Springer India 2014

Authors and Affiliations

  1. 1.Department of OtolaryngologyCatholic University of CórdobaCórdobaArgentina
  2. 2.National University of CórdobaCórdobaArgentina
  3. 3.Head of clinical Support, Business Unit Vibrant, Med-El.InnsbruckAustria

Personalised recommendations